EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
Main Authors: | Marco Ladetto, Martin Dreyling, on behalf of the EHA Guidelines Committee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000351 |
Similar Items
-
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
by: Kim Linton, et al.
Published: (2020-10-01) -
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
by: Marco Ladetto, et al.
Published: (2021-05-01) -
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
by: Barbara Eichhorst, et al.
Published: (2021-01-01) -
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
by: Philipp B. Staber, et al.
Published: (2021-10-01) -
EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)